As the COVID-19 pandemic spreads worldwide and the number of affected individuals continues to grow, the race is on to find a cure for the novel coronavirus. COVID-19 is a strain from the coronavirus family that causes illness from as mild as the common cold to more severe cases such as pneumonia, severe acute respiratory syndrome, kidney failure, and to the most extreme case, death.
Artificial Intelligence is an emerging transformative technology that is poised to revolutionize the way we live. The race is on to build AI systems that successfully simulate human intelligence. Companies have begun to recognize the advantages AI can bring into their products and have started pouring investments into research & development (R&D) efforts in the field, investing in larger compute power, and acquiring talent from universities and start-up companies. Notably, the increasing adoption of AI has resulted into a predicted significant growth increase in the AI market, with market growth rate estimates reaching as high as 60% for 2017-2022 [1].
Services
Links
Sign up to receive first access to reports, the latest patent news, and other updates.
Sign up to receive first access to our reports, the latest patent news, and other updates —
all delivered to your inbox.
Sign up now to receive monthly patent news, analysis and free insight reports.
We don’t spam, we promise.